Tailoring precision immunotherapy: coming to a clinic soon?

Cell-based and antibody-based cancer immunotherapies have been widely tested across increasing numbers of cancers with an unprecedented number of successful practice-changing immunotherapy clinical trials, achieving significant survival outcomes and, characteristically, some very long-term survivors...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Shuting, Shuen, Wai Ho, Wang, Who-Whong, Nazim, Esdy, Toh, Han Chong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046383/
https://www.ncbi.nlm.nih.gov/pubmed/33558033
http://dx.doi.org/10.1136/esmoopen-2019-000631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046383/
https://www.ncbi.nlm.nih.gov/pubmed/33558033
http://dx.doi.org/10.1136/esmoopen-2019-000631

Ejemplares similares